Scientists at California Institute of Technology have developed a breakthrough technology that can completely change medical care monitoring: printed nanoparticles sensors can continue to track everything from vitamin to cancer drugs through human sweat. This innovation makes us closer to truly personalized drugs and can accurately customize treatment for the needs of each patient.
Professor of Medical Engineering at California Institute of Technology, the research author published in “Natural Materials”, “These are just two possible examples.” “These sensors now have many chronic diseases and their biomarkers, so that we may be continuous and continuous and continuous and continuously. Invincible monitoring “”
This technology has been proven to effectively monitor the metabolites of patients with long -term interconnection, and track the level of chemotherapy drugs of cancer patients in Hope patients in Du Alt, California. The key innovation is special nanoparticles, which can be printed like ink, producing flexible quality, wearable sensors.
Researchers describe nano particles as nuclear shell cubic structures. These tiny cubes are formed in a solution containing a specific molecule to be tracked. As a particle formation, they will produce precise molecular “holes”, which can capture and measure the same molecules in a person’s sweat in the future.
“This core is crucial. Even in the biomoto, the core of nickel hexacinyl methyl ester is highly stable, making these sensors very suitable for long -term measurement.
When researchers create sensors to measure multiple amino acids, metabolites, hormones and drugs in the sweat at the same time, only the different nanoparticles “ink” in a single array can measure the various amino acids, metabolic products, hormones and drugs in the sweat At the same time, it proves the multifunctional nature of the technology. The sensor can also be implanted under the skin for more accurate monitoring.
GAO said: “Prove the potential of this technology, we can monitor the amount of cancer drugs in the body at any given time.” “This is not only targeted at the dosage of cancer, but also for many other diseases.”
This study was supported by the National Science Foundation, the National Health Research Institute, the US Cancer Association, the Naval Research Office, the Army Research Office, NASA, the Institute of Heritage Medical Institute and the Hope Biomedical Initiative.
If you find this work useful, consider supporting our work through one -time or monthly donations. Your contribution allows us to continue to bring you the accuracy that you can trust, and to be deeply scientific and medical news. Independent reports take time, energy and resources, and your support makes us likely to continue to explore stories important to you. Together, we can ensure that important discovery and development attracts them the most.
